Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026?
Health & MedicineOne-Off3mManifold MarketsSin KYCDatos de resolución verificadosCalibración aceptablePronóstico comunitario actualNo 92.9%
Pronosticadores
4
Tipo de pregunta
binary
Metodología
Play-money forecasting platform
Tipo de fuente
Pronóstico
Datos de mercado
Actualizado hace 7 horas
Desactualizado5 sept 23, 9:52 UTC31 dic 26, 22:59 UTC
Tendencias
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
When will Tesla Cybertruck be available in Europe?
Manifold MarketsWill the FDA approve any psychedelic substance for medical use this year?
KalshiWill Drift0r's medical problem be found before 2027?
Manifold MarketsWhat will be true of the explosion at Harvard Medical School?
Manifold MarketsHantavirus pandemic in 2026?
PolymarketMeasles cases in 2026?
KalshiReglas
The clinical trials for fat tissue regrowing implants have already started in France and Spain.
- It is projected to finish in 2025.
- And it will change the silicon paradigm in plastic surgery.
- Will this technology be available for reconstructive or aesthetic breast surgery by the end of 2026 outside of clinical trials?
- https://www.theguardian.com/society/2022/jul/03/breast-reconstruction-cancer-silicone-implants-regrowing
- [link preview]
Mercados abiertos
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No+0.4pt97%
- Yes-0.4pt3%
- Volumen total
- 15,7 M €
- Volumen 24h
- 52,2 mil €
KALSHIMeasles cases in 2026?
- Above 4000+2.0pt99%
- Above 300099%
- Above 600061%
+2 resultados más
- Volumen total
- 870,4 mil €
- Volumen 24h
- 2,1 mil €
POLYMARKETNew pandemic in 2026?
- No-1.0pt93.1%
- Yes+1.0pt6.9%
- Volumen total
- 922,5 mil €
- Volumen 24h
- 1,8 mil €
KALSHICyclosporiasis cases reported in the US in 2026?
- Above 18k99%
- Above 6k99%
- Above 10k99%
+12 resultados más
- Volumen total
- 32,4 mil €
- Volumen 24h
- 1,3 mil €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes+0.4pt3%
- Volumen total
- 1,6 M €
- Volumen 24h
- 933,9 €
KALSHIHealthcare AI adoption in September
- Above 43%87%
- Above 43.75%59%
- Above 45%14%
+4 resultados más
- Volumen total
- 810,1 €
- Volumen 24h
- 767 €
- FDA decision: Ivonescimab by Summit Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- Measles cases in U.S. by September 30?
- What will the average number of measles cases be during Trump's term?
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Will the FDA approve any psychedelic substance for medical use this year?
- Pandemic in 2026?
- How many human screwworm cases will be reported in the United States in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- Which countries will have an Ebola case in 2026?
- Ebola: new country confirmed before October 1?
Preguntas frecuentes
- ¿Cuáles son las probabilidades actuales de Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026??
- Manifold Markets cotiza No al 93% a fecha de 11 de septiembre de 2026.
- ¿Cuándo se resuelve Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026??
- Está previsto que Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026? se resuelva el 31 de diciembre de 2026.
- ¿Cómo se liquida Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026??
- Manifold Markets liquida este mercado del siguiente modo: The clinical trials for fat tissue regrowing implants have already started in France and Spain.